These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35451166)

  • 1. Does hyaluronidase injected in periocular area change skin ultrastructure?: Standardized in vitro analysis.
    Aguilar-González M; Davó-Cabrera J; Rausell-Fontestad N; Botella-Estrada R; España-Gregori E; Pérez-López M
    J Cosmet Dermatol; 2022 Oct; 21(10):4323-4327. PubMed ID: 35451166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rehabilitation of the Dysmorphic Lower Eyelid From Hyaluronic Acid Filler: What to Do After a Good Periocular Treatment Goes Bad.
    Skippen B; Baldelli I; Hartstein M; Casabona G; Montes JR; Bernardini F
    Aesthet Surg J; 2020 Jan; 40(2):197-205. PubMed ID: 30877762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild Complications or Unusual Persistence of Porcine Collagen and Hyaluronic Acid Gel Following Periocular Filler Injections.
    Wolkow N; Jakobiec FA; Dryja TP; Lefebvre DR
    Ophthalmic Plast Reconstr Surg; 2018; 34(5):e143-e146. PubMed ID: 29319639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of periocular fillers in aesthetic medicine.
    Mandal P; Gama F
    J Plast Reconstr Aesthet Surg; 2021 Jul; 74(7):1602-1609. PubMed ID: 33546985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular complications of hyaluronic acid fillers and the role of hyaluronidase in management.
    Kim DW; Yoon ES; Ji YH; Park SH; Lee BI; Dhong ES
    J Plast Reconstr Aesthet Surg; 2011 Dec; 64(12):1590-5. PubMed ID: 21807574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of Hylauronic Acid Fillers Using Hyaluronidase in an In Vivo Model.
    Ferraz RM; Sandkvist U; Lundgren B
    J Drugs Dermatol; 2018 May; 17(5):548-553. PubMed ID: 29742187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronidase: What is your fear?
    Bravo BSF; Bianco S; Bastos JT; Carvalho RM
    J Cosmet Dermatol; 2021 Oct; 20(10):3169-3172. PubMed ID: 34242464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed migration of soft tissue fillers in the periocular area masquerading as eyelid and orbital pathology.
    Lin Z; Dean A; Rene C
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33737282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing Periocular Filler-Related Syndrome Prior to Lower Blepharoplasty.
    Zoumalan CI
    Aesthetic Plast Surg; 2019 Feb; 43(1):115-122. PubMed ID: 30298348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Hyaluronidase on Depth of Necrosis in Hyaluronic Acid Filling-Related Skin Complications.
    Ors S
    Aesthetic Plast Surg; 2020 Oct; 44(5):1778-1785. PubMed ID: 32424534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating Sunken Upper Eyelid With Hyaluronic Acid: Recommendations and Results.
    Spada J
    J Drugs Dermatol; 2022 Sep; 21(9):1002-1008. PubMed ID: 36074507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of vascular complications following facial hyaluronic acid injection: High-dose hyaluronidase protocol: A technical note.
    Rouanet C; Kestemont P; Winter C; Lerhe B; Savoldelli C
    J Stomatol Oral Maxillofac Surg; 2022 Apr; 123(2):262-265. PubMed ID: 34157447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized in vitro analysis of the degradability of hyaluronic acid fillers by hyaluronidase.
    Buhren BA; Schrumpf H; Bölke E; Kammers K; Gerber PA
    Eur J Med Res; 2018 Aug; 23(1):37. PubMed ID: 30122153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Low Doses of Hyaluronidase to Remove Hyaluronic Acid Filler Nodules: A Randomized Clinical Trial.
    Alam M; Hughart R; Geisler A; Paghdal K; Maisel A; Weil A; West DP; Veledar E; Poon E
    JAMA Dermatol; 2018 Jul; 154(7):765-772. PubMed ID: 29710212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of retrobulbar hyaluronidase in the treatment of visual loss caused by periocular hyaluronic acid injection. A systematic review.
    Navarro-Hernandez E; Pérez-López M
    Arch Soc Esp Oftalmol (Engl Ed); 2022 Sep; 97(9):521-538. PubMed ID: 35787383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronidase: Understanding Its Properties and Clinical Application for Cosmetic Injection Adverse Events.
    Harrison J; Rhodes O
    Plast Surg Nurs; 2017; 37(3):109-111. PubMed ID: 28858168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Intraarterial Thrombolysis in Treatment of Cosmetic Facial Filler-Related Ophthalmic Artery Occlusion.
    Zhang LX; Lai LY; Zhou GW; Liang LM; Zhou YC; Bai XY; Dai Q; Yu YT; Tang WQ; Chen ML
    Plast Reconstr Surg; 2020 Jan; 145(1):42e-50e. PubMed ID: 31881603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Management of Nasal Skin Necrosis Caused by Hyaluronic Acid Filler.
    Vieira MG; Machado-Filho DA; Alcantara AR; Mendonça A; Kim JH; Gonzalez Cortes AR
    J Craniofac Surg; 2021 Mar-Apr 01; 32(2):e120-e122. PubMed ID: 33705046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers.
    Cavallini M; Gazzola R; Metalla M; Vaienti L
    Aesthet Surg J; 2013 Nov; 33(8):1167-74. PubMed ID: 24197934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rejuvenation of Aged Human Skin by Injection of Cross-linked Hyaluronic Acid.
    Cui Y; Wang F; Voorhees JJ; Fisher GJ
    Plast Reconstr Surg; 2021 Jan; 147(1S-2):43S-49S. PubMed ID: 33347074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.